High sensitive CRP test
About the parameter
C-reactive Protein (CRP) is the best known among the acute-phase proteins, a group of proteins whose concentration increases in blood as a response to inflammatory disorders.
A growing number of studies have examined that a more sensitive test, the so called hsCRP (high sensitive CRP), can predict recurrent cardiovascular disease, stroke and even death in different settings. High levels of hsCRP consistently predict recurrent coronary events in patients with unstable angina and acute myocardial infarction (heart attack).
Higher hsCRP levels also are associated with lower survival rates in these patients.
The Eurolyser hsCRP (high sensitive CRP) assay faciliates the determination of CRP levels with remarkable speed and precision.
Kinetic determination of the concentration of CRP by photometric measurement at 546 nm or 700 nm of antigen-antibody reaction between antibodies to human CRP bound to polystyrene particles and CRP present in the sample.
This test is an immunoturbidimetric assay with two ranges:
0.25 – 20 mg/l
0.50 – 20 mg/l
Test duration takes approx. 3 minutes measuring serum, approx. 4 minutes measuring whole blood.
More details can be found in the package insert.
Please note: All package inserts provided on this website are intended for information purposes only! Always process all tests, controls and calibrators strictly according to the package insert provided with the kit.
Find the evaluation study for the Eurolyser hsCRP assay here: Evaluation Eurolyser hsCRP
Please note: depending on the time of the market launch of an assay, the respective assay evaluation was carried out using either a Eurolyser smart instrument or a Eurolyser CUBE instrument.
Since the measurement method is the same in both instruments (their photometric units are identical in construction), as was proved in this comparison study, all testkit evaluations provided on this website are valid for either instrument!
ST 0105 hsCRP test kit (containing 32 tests)
ST 1005 hsCRP control kit (decision level)
18. August 2020
SDMA: A new veterinary assay for evaluation of chronic kidney diseases...» Read more...
17. August 2020
Phenobarbital: A next generation epilepsy monitoring assay...» Read more...
10. December 2019
Launch of bidirectional connectivity: a feature for CUBE series instruments...» Read more...
5. December 2019